Todd M. Anthony's most recent trade in Cumberland Pharmaceuticals Inc. was a trade of 3,000 Options (right to buy) done . Disclosure was reported to the exchange on March 17, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Cumberland Pharmaceuticals... | Todd M. Anthony | Vice Pres Organizational Dev | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Mar 2025 | 3,000 | 18,000 | - | - | Options (right to buy) | |
| Cumberland Pharmaceuticals... | Todd M. Anthony | Vice Pres Organizational Dev | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Mar 2024 | 3,000 | 15,000 | - | - | Options (right to buy) | |
| Cumberland Pharmaceuticals... | Todd M. Anthony | Vice Pres Organizational Dev | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.81 per share. | 23 Mar 2024 | 816 | 16,328 (0%) | 0% | 1.8 | 1,477 | Common Stock |
| Cumberland Pharmaceuticals... | Todd M. Anthony | Vice Pres Organizational Dev | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Mar 2023 | 3,000 | 12,000 | - | - | Options (right to buy) |